Bio-Rad Laboratories, Inc.
Stock Details
Is it expensive?
Trailing P/E Ratio
49.47
Forward P/E Ratio
30.58
PEG Ratio
-0.05
17.49
Price-to-Sales (TTM)
3.07
1.16
255.37
Market Cap
7.98B
7.78B
Is it profitable?
Net Profit Margin (TTM)
6.52%
Gross Profit Margin
52.25%
Diluted EPS (TTM)
6.01
2.50%
2.59B
Is it growing?
1.10%
1.14%
Is it risky?
1.09
20.12
3.21
1.38B
Who owns it?
94.46%
16.34%
0.00%
26.83M
20.91M
Does it pay?
0.00%
0.00%
--
--
How much cash?
1.56B
510.40M
229.76M
58.47
- Price
- 298.41
- Percent Change
- +0.83 (0.28%)
- Previous Close
- 297.58
- Open
- 296.18
- Low
- 294.81
- High
- 299.91
52-Week Range Position (52WRP)
Fairly Priced
Fairly Priced
within its 1-year price range
$298.41
From 52W Low
+26.05%
From 52W High
-13.03%
Today
+0.28%
1Y Change
+20.64%
6M
$322.06
3M
$295.96
1M
$289.28
Today
$298.41
From 52W Low
+26.05%
From 52W High
-13.03%
Today
+0.28%
1Y Change
+20.64%
6M
$322.06
3M
$295.96
1M
$289.28
Today
$298.41
Fairly Priced
within its 1-year price range
$298.41
Multi-Timeframe Analysis (MTA)
Uptrend
Most timeframes point up. One conflicting period introduces some uncertainty, but the overall direction is positive. Weaker than a Strong Uptrend, but still a bullish signal. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+3.2%
3M
+0.8%
6M
-7.3%
1Y
+20.6%
Rate of Change (ROC)
Accelerating
Price is rising 10.5x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Bio-Rad Laboratories, Inc.
- Founded
- 1952
- CEO
- Norman D. Schwartz
- Employees
- 7,450
- Fiscal Year End
- Dec 31, 2025
- Address
1000 Alfred Nobel Drive
Hercules
California
94547
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.bio-rad.com
Indicators
Operating Cash Flow
510.40M
Net Income
168.80M
Real Earnings
3.02
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Indicators
Operating Cash Flow
510.40M
Net Income
168.80M
Real Earnings
3.02
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
49.47
Forward P/E Ratio
30.58
PEG Ratio
-0.05
17.49
Price-to-Sales (TTM)
3.07
1.16
255.37
Market Cap
7.98B
7.78B
Is it profitable?
Net Profit Margin (TTM)
6.52%
Gross Profit Margin
52.25%
Diluted EPS (TTM)
6.01
2.50%
2.59B
Is it growing?
1.10%
1.14%
Is it risky?
1.09
20.12
3.21
1.38B
Who owns it?
94.46%
16.34%
0.00%
26.83M
20.91M
Does it pay?
0.00%
0.00%
--
--
How much cash?
1.56B
510.40M
229.76M
58.47
- Price
- 298.41
- Percent Change
- +0.83 (0.28%)
- Previous Close
- 297.58
- Open
- 296.18
- Low
- 294.81
- High
- 299.91
52-Week Range Position (52WRP)
Fairly Priced
Fairly Priced
within its 1-year price range
$298.41
From 52W Low
+26.05%
From 52W High
-13.03%
Today
+0.28%
1Y Change
+20.64%
6M
$322.06
3M
$295.96
1M
$289.28
Today
$298.41
From 52W Low
+26.05%
From 52W High
-13.03%
Today
+0.28%
1Y Change
+20.64%
6M
$322.06
3M
$295.96
1M
$289.28
Today
$298.41
Fairly Priced
within its 1-year price range
$298.41
Multi-Timeframe Analysis (MTA)
Uptrend
Most timeframes point up. One conflicting period introduces some uncertainty, but the overall direction is positive. Weaker than a Strong Uptrend, but still a bullish signal. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+3.2%
3M
+0.8%
6M
-7.3%
1Y
+20.6%
Rate of Change (ROC)
Accelerating
Price is rising 10.5x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Bio-Rad Laboratories, Inc.
- Founded
- 1952
- CEO
- Norman D. Schwartz
- Employees
- 7,450
- Fiscal Year End
- Dec 31, 2025
- Address
1000 Alfred Nobel Drive
Hercules
California
94547
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.bio-rad.com